Cadwalader Reps Pfizer In $3.6B King Pharma Buy
The companies announced the deal in a joint statement Tuesday, which stated that Pfizer will pay $14.25 per share for King, a 40 percent premium on King's Monday closing price. The deal had the approval of the boards of both companies, the statement said.
The deal is the largest for Pfizer since its $68 billion acquisition of Wyeth Inc. was cleared by the Federal...
To view the full article, register now.